Generation bio to present at the 2024 td cowen genetic medicines & rna summit

Cambridge, mass., june 14, 2024 (globe newswire) -- generation bio co. (nasdaq:gbio) a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that geoff mcdonough, m.d., president and chief executive officer, will participate in a fireside chat at the virtual 2024 td cowen genetic medicines & rna summit on friday, june 21st, 2024 at 1:50 p.m. et.
COWN Ratings Summary
COWN Quant Ranking